Cosmetic Compositions for Skin Firming Using Escin Extracts
Summary
USPTO published Mary Kay Inc.'s patent application for cosmetic compositions containing escin and botanical extracts for treating sagging, loose skin and improving facial contouring. The application includes methods comprising topical application of compositions with escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, and other plant-based ingredients. This is an informational publication with no regulatory compliance requirements.
What changed
USPTO published patent application US20260090980A1 for Mary Kay Inc., covering cosmetic compositions and methods for treating skin to improve the appearance of droopy, loose, sagging, or flaccid skin and facial contouring. The disclosed compositions include escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officinalis leaf extract, and Morus alba fruit extract. The application was filed September 22, 2023, and published April 2, 2026.
Patent applications are informational publications and do not create regulatory obligations or compliance deadlines. No action is required from cosmetic manufacturers or other regulated entities. Companies developing similar skin firming or contouring products may wish to review the claims to assess potential intellectual property considerations.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME
Application US20260090980A1 Kind: A1 Apr 02, 2026
Assignee
MARY KAY INC.
Inventors
Geetha KALAHASTI
Abstract
The present invention relates generally to methods and compositions useful for treating skin, and in particular to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring. In some aspects, disclosed are methods comprising topically applying to the skin an effective amount of a topical composition comprising escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract.
CPC Classifications
A61K 8/9711 A61K 8/4953 A61K 8/922 A61K 8/9789 A61K 8/9794 A61Q 19/08
Filing Date
2023-09-22
Application No.
19113771
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.